mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |